baber/WOPTO huggingface dataset:
Patent FI-990300-A0 (FI)
Inventor: NIEMELAE MARKKU
IPC: H02P21/24
Filed: 1999-02-15
Abstract: A method of correcting the stator flux estimate midpoint in alternating-current systems, the method comprising the step of determining a stator flux estimate (Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00001"/>s, est?). The method is characterized in steps of forming the sum of the squares of the rectangular components (Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00002"/>sx, est?, Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00003"/>sy, est?) of the stator flux estimate to obtain a reference variable (k), low-pass filtering the reference variable (k) in order to obtain a low-frequency component (kfilt) of reference variable, subtracting the low-frequency component (kfilt) from the reference variable (k) in order to obtain a difference variable (e), determining rectangular correction term components (Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00004"/>sx, corr?, Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00005"/>sy, corr?) of the stator flux estimate (Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00006"/>s, est?) by multiplying the difference variable (e) by the rectangular components (Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00007"/>sx, est?, Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00008"/>sy, est?) of the stator flux and a correction coefficient (KΨcorr), and forming a midpoint-corrected stator flux estimate (Ψ<CUSTOM-CHARACTER FILE="US06600290-20030729-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00009"/>s, fin?) by adding the correction term components to the components of the stator flux estimate.
Patent IL-75788-A0 (IL)
Title: Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
IPC: A61K39/00
Filed: 1985-07-12
Abstract: A protective peptide antigen corresponding to Plasmodium falciparum circumsporozoite. A DNA encoding the peptide is also disclosed. The peptide tandemly repeats at least twenty three times and comprises eptopes of Plasmodium falciparum CS protein.
Patent IL-76521-A0 (IL)
Title: 3-amino-2-benzoylacrylic acid derivatives and their preparation
IPC: C07C255/58
Filed: 1985-09-27
Abstract: Novel 3-amino-2-benzoyl-acrylic acid derivatives of the formula <IMAGE>   in which R1 represents the nitrile group, an ester group -COOR4 or carboxamide group   <IMAGE>  R4 denoting C1-C6-alkyl, and R5 and R6 representing hydrogen or C1-C3-alkyl or phenyl, R2 and R3, which can be identical or different, represent a C1-C6-alkyl radical and, furthermore, can form, together with the nitrogen atom to which they are bonded, a 5- or 6-membered heterocyclic ring which can additionally contain as ring member the atoms or groups -O-, -S-, -SO- or -SO2-, X represents halogen, X1 denotes hydrogen, methyl, nitro or halogen, X2 denotes halogen or methyl, and X3 denotes hydrogen or halogen, are prepared by reacting    <IMAGE>  The products can be converted into known antibacterials.
Patent IL-89369-A0 (IL)
Title: Substituted 1,2,4-triazinediones,their preparation and their use
IPC: A01N43/78
Filed: 1989-02-21
Abstract: Novel substituted 1,2,4-triazinediones of the general formula I 
<IMAGE>
 in which
 R<1> represents heteroaromatic radicals bonded via carbon and which are optionally substituted,
 X represents O, S, SO or SO2, R<2> represents one or more, identical or different radicals of the group comprising hydrogen, halogen, nitro, alkyl, alkoxy, haloalkyl and haloalkoxy and
 R<3> represents hydrogen, optionally substituted alkyl, alkenyl, alkynyl or aralkyl,
 process for their synthesis and intermediates therefor. The compounds of the formula I are used for combating parasitic protozoa.
Patent IL-92413-A0 (IL)
Title: Single-use syringe
IPC: A61M5/31
Filed: 1989-11-23
Abstract: PCT No. PCT/EP89/01408 Sec. 371 Date Jul. 10, 1991 Sec. 102(e) Date Jul. 10, 1991 PCT Filed Nov. 20, 1989 PCT Pub. No. WO90/00614 PCT Pub. Date Jun. 14, 1990.The syringe has a tubular body slidably housing a plunger connected to a needle, movable between a first, safe position and a second, working position, respectively retracted into and extended from the body, and a spring biasing the needle toward its retracted position. An expansible retaining member is attached to one end of the needle and overrides a step, defined on the tubular body, as the needle is moved from the first to the second position. An expander device is carried movably on the plunger and adapted to be received and held in a socket formed in the retaining member to expand it and hold the needle in the working position. An annular rib is provided on a lug connected to the plunger for dislodging the retaining member from the step and release the needle, which is returned by the spring to its first position, out of sight inside the tubular body.
Patent IL-98163-A0 (IL)
Title: Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides,pharmaceuticals containing these compounds and their use
IPC: A61K31/505
Filed: 1991-05-16
Abstract: Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use Isoxazole-4-carboxamide derivatives and hydroxyalkylidene-cyanoacetamide derivatives are suitable for the treatment of carcinoses. These compounds can be prepared by known processes. Some of the compounds are novel and are additionally suitable for the treatment of rheumatic disorders.
Patent IL-98762-A0 (IL)
Title: Diaminotrifluoromethyl-pyridine derivatives,process for their production and phospholipase a2 inhibitor containing them
IPC: C07D213/76
Filed: 1991-07-08
Abstract: A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: <CHEM> wherein X is -CW<1>R<1>, -COCOR<2>, -CW<1>NHCOR<2>, -C(=W<1>)W<2>R<3> or -CW<1>N(R<4>)R<5>, and Y is alkyl, -CW<3>R<6>, -COCOR<7>, -NHCOR<7>, -C(=W<3>)W<4>R<8>, -(NH)mSO2R<9>, -(NH)mSO2OR<1><0> or -(NH)mSO2N(R<1><1>)R<1><2>, wherein each of R<1>, R<6> and R<9>, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R<2> and R<7>, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R<3>, R<8> and R<1><0>, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R<4>, R<5>, R<1><1> and R<1><2>, which are independent from one another, is alkyl which may be substituted, each of W<1>, W<2>, W<3> and W<4>, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is -COCF2X<1> wherein X<1> is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is -COCF2X<2> wherein X<2> is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or -COOX<3> wherein X<3> is alkyl which may be substituted or phenyl which may be substituted, is excluded.
Patent SE-9404211-A0 (SE)
Title: Förfarande för anrikning av hartssyror ur lövvedhaltig sulfatsåpa
Inventor: TANNER TEEMU
IPC: C11D15/04
Filed: 1994-12-05
Abstract: 8 Sammandrag Uppfinningen avser ett forfarande fOr anrikning av hartssyror ur en 16vvedhaltig sulfatsapa, varvid sapan surgOrs partiellt med en oorganisk eller organisk syra, sá att den harvid bildade moderlutens pH 8r 4,5 - 7, varvid hartssy- rorna anrikas ur sapan i den till syraform omvandlade delen och fettsyrorna anrikas i sjalva sapan.
Patent AU-PP159698-A0 (AU)
Title: Improved blood coagulation test
IPC: C12Q1/56
Filed: 1998-02-02
Abstract: A method of determining the coagulation potential of a plasma sample be pre-incubating the plasma sample with a reagent such that endogenous protein C in the plasma is at least partially converted into activated protein C by the reagent, adding factor Xa which is progressively inactivated by antithrombin III/heparin cofactor 2 during the preincubation, adding an exogenous reagent which activates factor X to Xa or prothrombin to thrombin in a factor V-dependent manner, monitoring a reaction indicative of the rate of coagulation of the plasma sample, comparing that rate of coagulation control, or the equivalent rate determined for an individual without impaired coagulation control, or the equivalent rate determined for the plasma sample in the absence of protein C activator, and determining the coagulation potential of the plasma sample from one or other of the compairsons.
Patent FI-20000732-A0 (FI)
Inventor: NYBERG KAISA
IPC: H04L9/32
Filed: 2000-03-30
Abstract: To provide reliable and customized authentication, a parameter to be used in authentication is defined for the operator. A secret which may be stored e.g. in a subscriber identity module is calculated from the operator parameter and a subscriber key. An authentication response is calculated from the secret and the challenge to be used in authentication with a one-way function.
Patent FI-20012149-A0 (FI)
Inventor: KARHU NIILO
IPC: E05D15/06
Filed: 2001-11-07
Abstract: An arrangement for providing a swivel point (10) for the bottom end of panel-like elements (4), especially terrace enclosing glass elements or the like partition elements, movable along upper and lower guide rails (2, 3), said elements (4) comprising first and second lower guide means (5, 6) provided at the bottom edge of an element, said lower guide means in turn comprising a body portion (7), and a guide portion (8) bearing against the lower guide rail (3), and said lower guide means (5, 6) being adapted to support the element (4) in its vertical direction and to guide the element crosswise wit respect to the lower guide rail (3), a first upper guide means (9) provided at the top of the element (4), which is adapted to guide the element (4) crosswise with respect to the upper guide rail (2), and the element being pivotable at said swivel point (10) about a pivoting axle (11) established by the first upper guide means (9) present at the top edge of the element and by the first lower guide means (5) present at the bottom edge of the element. The swivel point (10) is included in a guide member (12), which is adapted to function as an extension of the lower guide rail (3) and upon which the first lower guide means (5) is adapted to travel while supported by its body portion (7), or a portion separately adapted to extend therefrom, in the lengthwise direction of the lower guide rail (3), and that the second lower guide means (6) is adapted to disengage from the lower guide rail (3) when the first lower guide means (5) is at said swivel point (10).
Patent FI-20021312-A0 (FI)
Inventor: EROMA OLLI-PEKKA
IPC: A23L27/30
Filed: 2002-07-03
Abstract: The present invention relates to a microcrystallized polyol comprising at least two polyols, wherein said polyols are selected from the group consisting of maltitol, xylitol and lactitol and wherein said composition contains at least 25 % by weight of each of at least two of said polyols microcrystallized together into a solid microcrystalline product. The present invention also relates to a process for the microcrystallization of polyols into a polyol composition. The microcrystallized polyol composition can be used in confectionery, foodstuffs, oral hygiene products and pharmaceuticals and in dietetic products.
Patent FI-20031527-A0 (FI)
Inventor: JOKELA HARRI
IPC: H04M3/487
Filed: 2003-10-17
Abstract: For advance assessment of a subscriber's communication capability, i.e. how likely he is to answer a call or detect an incoming message, for example, even when his telephone or other terminal is not engaged, at least one attribute is specified whose value indicates to a telecommunication system whether (404) or not the subscriber is likely to be capable of communication when the subscriber line is not occupied, the value of the attribute being maintained subscriber-specifically. <IMAGE>
Patent FI-20115861-A0 (FI)
Inventor: RIIVARI PETTERI
IPC: B01D/
Filed: 2011-09-02
Abstract: A disc filter comprises a supply box (11) and a vat (8), whereby fibre pulp suspension to be supplied into the disc filter (1) is supplied to the vat (8) through the supply box (11). The disc filter (1) comprises at least one flow control element (30, 32, 44, 49) arranged to act on at least part of the flow (F) of the fibre pulp suspension to be supplied through the supply box (11) to the vat (8).  Also a method for supplying fibre pulp suspension into a disc filter (1).
Patent IL-101896-A0 (IL)
Title: Diltiazem formulation
IPC: A61P9/08
Filed: 1992-05-17
Abstract: The present invention is directed to a diltiazem formulation suitable for one a day administration. The formulation contains a blend of diltiazem beads having two differing dissolution profiles. <IMAGE>   <IMAGE>
Patent IL-125662-A0 (IL)
Title: Method of detecting influenza virus and compounds for use therein
IPC: C07D495/04
Filed: 1997-02-26
Abstract: The invention provides a method of detection of influenza virus which utilizes compounds able to bind specifically to the active site of influenza virus neuraminidase, and novel compounds for use in the method.
Patent IL-132461-A0 (IL)
Title: Method of manufacturing sertindole
IPC: A61K47/00
Filed: 1998-05-07
Abstract: A process of manufacturing sertindole comprising reacting 5-chloro-1-(4-fluorophenyl)indole with 4-piperidone in a mixture of an acetic acid and concentrated HCl; reduction of the resulting 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole and reaction of this compound with 1-(2-chloroethyl)-2-imidazolidinon in order to obtain sertindole.
Patent IL-144416-A0 (IL)
Title: Oscillator using calibration means
IPC: H03L7/14
Filed: 2000-01-20
Abstract: A method for calibrating a frequency device by monitoring its output cycles over a first plurality of monitoring windows is disclosed. An accumulation of these monitored cycles is used to determine a correction for the device over a second plurality of monitoring windows. A method for obtaining fractional correction values to be applied for controlling the frequency device is also disclosed.
Patent IL-146491-A0 (IL)
Title: APo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM
IPC: A61K39/395
Filed: 2000-06-07
Abstract: Methods of using synergistically effective amounts of Apo-2L receptor agonists and CPT-11 to induce apoptosis and suppress growth of cancer cells, are provided.
Patent IL-153297-A0 (IL)
Title: Compounds and compositions for delivering active agents
IPC: A61K38/28
Filed: 2001-06-29
Abstract: Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provide as well.
Patent IL-153815-A0 (IL)
Title: Low profile infusion set
IPC: A61M5/178
Filed: 2001-06-08
Abstract: An infusion set for administration of fluid to a subcutaneous layer includes a cannula housing adapted for mounting onto a patient's skin and a needle housing for connection to the cannula housing. The needle housing has a pair of flexible sidewalls and a resilient band connected to the sidewalls. The resilient band is lockably engageable with the cannula housing to thereby secure the housings together, and is releasable from the cannula housing when the sidewalls are pressed toward each other to deform the resilient band. A hollow needle extends out of a main body of the needle housing for delivering fluid to the cannula from a fluid source. The walls of the needle housing extend beyond a distal end of the hollow needle to prevent needle contact with contaminated surfaces and inadvertent injury.
Patent IL-154663-A0 (IL)
Title: Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3'
IPC: C12M1/00
Filed: 2001-09-01
Abstract: Determining the degree of methylation of a particular cytosine in a motif 5'-CpG-3', present in a genomic sample of DNA (I), is new. Determining the degree of methylation of a particular cytosine in a motif 5'-CpG-3', present in a genomic sample of DNA (I), is new. The sample is treated chemically to convert cytosine (C), but not methylated C, to uracil, then part of (I) that contains the target C is amplified to form a labeled amplicon (II). (II) is hybridized to two classes, each with at least one member, of oligonucleotides and/or peptide-nucleic acid (PNA) oligomers (A) and the degree of hybridization to both classes is determined from the label on (II). From the ratio of labels hybridized to the two classes of (A), the degree of methylation is calculated. Independent claims are also included for the following: (1) a kit comprising a bisulfite, primer oligonucleotides for amplification, and/or (A), preferably immobilized on a solid phase, plus instructions; (2) a nucleic acid comprising at least 18 bases from chemically pretreated DNAs (B) of sequences (1) - (40712), not given in the specification; (3) oligonucleotide or PNA oligomers (OG) for use in the new process comprising a sequence of at least 9 nucleotides (nt) able to hybridize to (B); (4) sets of OG; (5) sets of at least two primer oligonucleotides for amplifying at least one (B) or its segment; (6) sets of oligonucleotide probes for determining the degree of C methylation and/or single nucleotide polymorphisms in (B), comprising at least ten OG; (7) preparing carrier-bound arrays of different OG for analysis of diseases associated with the methylation status of (B), by attaching OG to a solid phase; and (8) arrays made by (7).
Patent IL-165208-A0 (IL)
Title: A support member system
IPC: E04C3/00
Filed: 2004-11-15
Abstract: A support member system includes a set of elongate members (2). Each elongate member (2) has a first end (53) and a second end and a predetermined length. The predetermined length of each elongate member (2) is different from the predetermined length of each of the other elongate members (2). An end member (10) has an elongate member engagement portion (12, 13) adapted to engage with the first end (53) of an elongate member (2), and a support structure engagement portion (15). The support structure engagement portion (15) is adapted to engage with a support structure (8). The elongate member engagement portion (12, 13) permits the distance from the wall engagement portion (15) to the second end of the elongate member (2) to be adjustable at least up to the length of the next longer elongate member (2) in the set.
Patent IL-177761-A0 (IL)
Title: Oil containing starch granules for delivering benefit-additives to a substrate
IPC: C11D3/30
Filed: 2006-08-29
Abstract: An oil containing starch granule comprising: 
(a) a starch, said starch forming a matrix for said granule; 
(b) a perfume oil comprising ingredients having a calculated Clog P of at least 3, said Clog P being the calculated octanol to water partition coefficient, said perfume oil being capable of providing a benefit-additive to a substrate upon contact therewith, said substrate being selected from the group consisting of fabrics, hard surfaces, hair and skin; and 
(c) an effective amount of a quaternary ammonium compound for inhibiting the migration of said oil to the surface of said starch granule, said compound being represented by the following structure:     
wherein R 1  and R 2  are each independently, H or: 
(a) C 1 -C 22  alkylenecarboxy moiety having the formula: 
-(CH 2 ) e R 3  wherein R 3  is -NHCOR 4 ; or -OCOR 4 ; or -NR 5 COR 4 ; and wherein R 4  and R 5  are each independently C 1 -C 22  akyl or alkenyl; and e is an integer from 1 to 22; or  
(b) C 1 -C 22  linear or branched alkyl; or 
(c) C 1 -C 22  linear or branched alkenyl; or 
(d) C 2 -C 22  substituted or unsubstituted alkylenoxy; or 
(e) C 3 -C 22  substituted or unsubstituted alkylenoxy alkyl; or 
(f) C 6 -C 22  substituted or unsubstituted aryloxy; or 
(g) C 7 -C 22  substituted or unsubstituted alkylenearyl; or 
(h) C 7 -C 22  substituted or unsubstituted alkyleneoxyaryl; or 
(i) C 7 -C 22  oxyalkylenearyl; or 
(j) an anionic unit having the formula:  
- (CH 2 ) y R 6    
wherein R 6  is -SO 3 M, -OSO 3 M, -PO 3 M, -OPO 3 M, Cl or mixtures thereof, wherein M is hydrogen, or one or more salt forming cations sufficient to satisfy charge balance, or mixtures thereof; R 6  may also be choloride; y is an integer from 1 to about 22; and 
(k) a mixture comprising at least two of (a) through (j); and 
q is an integer from 0 to about 22; m is an integer from 0 to about 22; Q is (CH 2 ) m  or (CH 2 CHR 7 O); R 7  is independently hydrogen, methyl, ethyl, propyl or benzyl; and mixtures thereof; B is H or OH; Y is N; R 8  is H or C 1 -C 4  alkyl,; Z -  is a counter anion, and preferably chloride,or methyl sulfate.
Patent IL-182908-A0 (IL)
Title: Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
IPC: A61P25/00
Filed: 2007-05-01
Abstract: Disclosed is a method of treating fibrosis in a human or animal subject. The method comprises administering to the subject an effective amount of an antibody to an integrin or fragment thereof.
Patent IL-188429-A0 (IL)
Title: High security aircraft
Filed: 2007-12-26
Abstract: An aircraft comprising an elongated framework provided with propelling means and direction-control planes. The framework is coupled to a pneumatic chamber suited to be filled with lighter-than-air gas and comprising two tubular branches joined to form a V-shaped profile, with an aerodinamic-lift surface extending therebetween.
Patent RO-131840-A0 (RO)
Title: Crenellated dental facets
Inventor: MĂROIU ALEXANDRA-CRISTINA
IPC: A61C13/08
Filed: 2017-01-18
Abstract: The invention relates to a crenellated dental facet made of non-metallic materials, used in dental treatments. According to the invention, the facet consists of a semi-opened shell (FC) which, at the inside, has a shape matching the frontal side of a tooth (D) prepared by trimming an enamel layer corresponding to the thickness of the shell (FC), the crenellated shell (FC) having some crenellated proximal edges which are made of three sinusoidal crenellations.
Patent RO-134539-A0 (RO)
Title: Semisolid pharmaceutical preparation for combined topical therapy of anorectal pathology
Inventor: SUCIU ALEXANDRU
IPC: A61P17/04
Filed: 2019-11-11
Abstract: The invention relates to a pharmaceutical preparation for combined topical therapy of anorectal pathology. According to the invention, the preparation consists of 0.01... 0.3% nitroglycerin, vitamin A, tocopherol and ascorbic acid, respectively, 0.01...0.5% lidocaine, 0.01...2% methanol or camphor and usnic acid, respectively, 0.01...1% hyaluronic acid, 0.01...5% capric acid or lauric acid, 0.01...20% partially hydrolyzed collagen and beeswax, respectively, 0.01...10% propolis, 0.01...30% bee honey and isolates of vegetable origin chosen between Aloe Barbadensis Miller, Matricaria recitita, Calendula officinalis, respectively, as well as pharmaceutically acceptable inactive ingredients for formulation as ointment, the percentage being expressed by mass.